Jinbiao Biotechnology

Shanghai Jinbiao specializes in the promotion of production technologies for rapid diagnostic and detection reagents, including gold-labeled immunoassay, colloidal gold immunochromatography, and latex immunochromatography test strips, primarily immunochromatographic detection technologies (such as colloidal gold test strips) and electrochemical electrode detection technologies (such as blood glucose test strips). The company's main products have been widely adopted by domestic diagnostic reagent manufacturers, making it a leading service provider in China's rapid diagnostic reagent industry. With further improvement in product quality and appearance, the company will launch high-quality immunological diagnostic and detection research tools for the broader scientific research community, helping researchers promptly convert R&D products into scientific and technological achievements. The company's experts have extensive experience in automation control software and hardware, possessing strong instrument development capabilities. In 2007, the company purchased CNC milling machines and CNC medium-speed wire-cut EDM machines; in 2008, it added precision machining equipment such as CNC grinders and lathes, enabling rapid project development and production of products with special specifications as per customer requirements. The company places great emphasis on product quality and has built two clean workshops for raw material consumable production and instrument assembly. In April 2007, the company successfully passed the ISO 9001:2000 quality management system certification. Shanghai Quicking Biotech Co., Ltd. (Quicking), a sister company of Jinbiao Biotechnology, was established in 2006 as a high-tech biotech enterprise co-founded by doctors with years of study and work experience in Europe and the United States, along with several senior in vitro diagnostic technology experts in China. In 2013, Quicking built the Quicking Biological Park in Shanghai Zhangjiang Science City, completed a 20,000-square-meter plant in 2016, and constructed a GMP clean production workshop and R&D laboratory of over 2,500 square meters in 2017, successfully developing more than 50 products to date. Quicking is dedicated to building a leading in vitro diagnostic reagent brand. Leveraging its years of innovative patent technology platforms, it has carved a development path in the IVD field, using innovative patented technologies to drive industry growth.